Previous close | 27.91 |
Open | 27.61 |
Bid | 28.80 x 1200 |
Ask | 28.99 x 1000 |
Day's range | 27.38 - 29.72 |
52-week range | 13.84 - 62.49 |
Volume | |
Avg. volume | 1,553,448 |
Market cap | 1.207B |
Beta (5Y monthly) | -0.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.16 |
Earnings date | 27 Feb 2023 - 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 13 Dec 2012 |
1y target est | 84.00 |
Here is how Mesa Labs (MLAB) and Cassava Sciences, Inc. (SAVA) have performed compared to their sector so far this year.
Shares of Cassava are moving higher on news that its rival Roche suffered a setback in its Alzheimer's drug research trial.
Cassava Sciences (SAVA) is expected to provide an update on its pipeline candidates during its third-quarter earnings.